Boulding Mark Elliott sold PTCT
May 8, 2026 · Form 4 insider transaction
Boulding Mark Elliott sold 200 shares of PTC Therapeutics, Inc. at $78.00 per share, a transaction worth $15.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$78.00
Total value
$15.6K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 8, 2026
Filing dateMay 12, 2026
Shares owned after105,812
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.